AAAAAA

   
Results: 1-11 |
Results: 11
COMBINATION OF GEMCITABINE (GEM) AND CARBOPLATIN (CARBO) AS FIRST LINE TREATMENT IN NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: CARRATO A ALBEROLA V MASSUTI B GALAN A SANCHEZ JJ GARCIAGOMEZ J DIAZFERNANDEZ N MEANA A RODRIGUEZLESCURE A GONZALVEZ ML
Citation: A. Carrato et al., COMBINATION OF GEMCITABINE (GEM) AND CARBOPLATIN (CARBO) AS FIRST LINE TREATMENT IN NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 431-431
HIGHER RISK OF EMESIS INDUCED BY CYCLOPHOSPHAMIDE COMBINATIONS CONTAINING ANTHRACYCLINES
Authors: ARANDA E GUILLEM V CARRATO A RIFA J LOPEZLOPEZ R BAMETO I CRUZ JJ SORIANO V RODRIGUEZLESCURE A LUQUE A
Citation: E. Aranda et al., HIGHER RISK OF EMESIS INDUCED BY CYCLOPHOSPHAMIDE COMBINATIONS CONTAINING ANTHRACYCLINES, Annals of oncology, 9, 1998, pp. 699-699
WEEKLY CONTINUOUS-INFUSION OF 5-FLUOROURACIL WITH ORAL LEUCOVORIN IN METASTATIC BREAST-CANCER PATIENTS WITH PRIMARY RESISTANCE TO DOXORUBICIN
Authors: NIETO Y MARTIN M ALONSO JL CASADO A AYALA F LOPEZMARTIN JA RODRIGUEZLESCURE A DIAZRUBIO E
Citation: Y. Nieto et al., WEEKLY CONTINUOUS-INFUSION OF 5-FLUOROURACIL WITH ORAL LEUCOVORIN IN METASTATIC BREAST-CANCER PATIENTS WITH PRIMARY RESISTANCE TO DOXORUBICIN, Breast cancer research and treatment, 50(2), 1998, pp. 167-174
EMETIC CONTROL IN BREAST-CANCER PATIENTS RECEIVING IV CMF - RESULTS OF 2 CONSECUTIVE STUDIES USING A NEW METHOD OF ASSESSMENT
Authors: MARTIN M ARANDA E DIAZRUBIO E CASADO A RUBIO MJ VALVERDE JJ LOPEZMARTIN JA RODRIGUEZLESCURE A BARNETO IC GONZALEZ R
Citation: M. Martin et al., EMETIC CONTROL IN BREAST-CANCER PATIENTS RECEIVING IV CMF - RESULTS OF 2 CONSECUTIVE STUDIES USING A NEW METHOD OF ASSESSMENT, Oncology Reports, 3(1), 1996, pp. 115-121
INCREASED RISK FOR HEPATOCELLULAR-CARCINOMA IN NAT2-SLOW ACETYLATORS AND CYP2D6-RAPID METABOLIZERS
Authors: AGUNDEZ JAG OLIVERA M LADERO JM RODRIGUEZLESCURE A LEDESMA MC DIAZRUBIO M MEYER UA BENITEZ J
Citation: Jag. Agundez et al., INCREASED RISK FOR HEPATOCELLULAR-CARCINOMA IN NAT2-SLOW ACETYLATORS AND CYP2D6-RAPID METABOLIZERS, Pharmacogenetics, 6(6), 1996, pp. 501-512
ACUTE AND ANTICIPATORY EMESIS IN BREAST-CANCER PATIENTS
Authors: FERNANDEZMARCOS A MARTIN M SANCHEZ JJ RODRIGUEZLESCURE A CASADO A MARTIN JAL DIAZRUBIO E
Citation: A. Fernandezmarcos et al., ACUTE AND ANTICIPATORY EMESIS IN BREAST-CANCER PATIENTS, Supportive care in cancer, 4(5), 1996, pp. 370-377
RSAI POLYMORPHISM AT THE CYTOCHROME P4502E1 LOCUS AND RISK OF HEPATOCELLULAR-CARCINOMA
Authors: LADERO JM AGUNDEZ JAG RODRIGUEZLESCURE A DIAZRUBIO M BENITEZ J
Citation: Jm. Ladero et al., RSAI POLYMORPHISM AT THE CYTOCHROME P4502E1 LOCUS AND RISK OF HEPATOCELLULAR-CARCINOMA, Gut, 39(2), 1996, pp. 330-333
RSAI POLYMORPHISM AT THE CYP2E1 LOCUS AND RISK OF PRIMARY LIVER-CANCER
Authors: BENITEZ J AGUNDEZ JAG LADERO JM RODRIGUEZLESCURE A DIAZRUBIO M
Citation: J. Benitez et al., RSAI POLYMORPHISM AT THE CYP2E1 LOCUS AND RISK OF PRIMARY LIVER-CANCER, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 21-21
CYP2D6 GENES AND RISK OF LIVER-CANCER
Authors: AGUNDEZ JAG LEDESMA MC BENITEZ J LADERO JM RODRIGUEZLESCURE A DIAZRUBIO E DIAZRUBIO M
Citation: Jag. Agundez et al., CYP2D6 GENES AND RISK OF LIVER-CANCER, Lancet, 345(8953), 1995, pp. 830-831
CLINICAL ACTIVITY OF CHRONIC ORAL ETOPOSIDE IN PREVIOUSLY TREATED METASTATIC BREAST-CANCER
Authors: MARTIN M LLUCH A CASADO A SANTABARBARA P ADROVER E VALVERDE JJ LOPEZMARTIN JA RODRIGUEZLESCURE A AZAGRA P GARCIACONDE J DIAZRUBIO E
Citation: M. Martin et al., CLINICAL ACTIVITY OF CHRONIC ORAL ETOPOSIDE IN PREVIOUSLY TREATED METASTATIC BREAST-CANCER, Journal of clinical oncology, 12(5), 1994, pp. 986-991
PREDNIMUSTINE-INDUCED MYOCLONUS - A REPORT OF 3 CASES
Authors: MARTIN M DIAZRUBIO E CASADO A VALVERDE JJ URRA DG LOPEZMARTIN JA RODRIGUEZLESCURE A
Citation: M. Martin et al., PREDNIMUSTINE-INDUCED MYOCLONUS - A REPORT OF 3 CASES, Acta oncologica, 33(1), 1994, pp. 81-82
Risultati: 1-11 |